Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes

AIDS Research and Human Retroviruses

Volumn 29, Issue 3, 2013, Pages 511-515

  Russell, Elizabeth S ^a,e   Ojeda, Suany ^a   Fouda, Genevieve G ^b   Meshnick, Steven R ^c   Montefiori, David ^b   Permar, Sallie R ^b   Swanstrom, Ronald ^a,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY 4E10; NEUTRALIZING ANTIBODY; NEVIRAPINE; SOLUBLE CD4 ANTIGEN; VIRUS DNA;

ADAPTIVE IMMUNITY; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BINDING SITE; BREAST FEEDING; BREAST MILK; DISEASE TRANSMISSION; ENVELOPE GENE; GENE AMPLIFICATION; GENE SEQUENCE; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANTIBODIES, NEUTRALIZING; BREAST FEEDING; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EPITOPES; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOLECULAR SEQUENCE DATA; PREGNANCY; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84874465405     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0197     Document Type: Article

References (44)

1. Rainwater SM, Wu X, Nduati R, et al.: Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. Curr HIV Res 2007;5: 189-197.
2. Russell ES, Kwiek JJ, Keys J, et al.: The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population. J Virol 2011;85:8253-8262.
3. Walker LM, Phogat SK, Chan-Hui PY, et al.: Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009;326:285-289.
4. Hocini H, Becquart P, Bouhlal H, et al.: Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-Associated virus across tight epithelial barriers. Clin Diagn Lab Immunol 2000;7:515-518.
5. Dunn DT, Newell ML, Ades AE, and Peckham CS: Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585-588.
6. Farquhar C, Mbori-Ngacha DA, Redman MW, et al.: CC and CXC chemokines in breastmilk are associated with motherto-child HIV-1 transmission. Curr HIV Res 2005;3:361-369.
7. Pancera M, McLellan JS, Wu X, et al.: Crystal structure of PG16 and chimeric dissection with somatically related PG9: Structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1. J Virol 2010;84: 8098-8110.
8. Verhofstede C, Demecheleer E, De Cabooter N, et al.: Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A. J Virol 2003;77:3050-3057.
9. Kwiek JJ, Russell ES, Dang KK, et al.: The molecular epidemiology of HIV-1 envelope diversity during HIV-1 subtype C vertical transmission in Malawian mother-infant pairs. AIDS 2008;22:863-871.
10. Mwapasa V, Rogerson SJ, Kwiek JJ, et al.: Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS 2006;20:1869-1877.
11. Salazar-Gonzalez JF, Bailes E, Pham KT, et al.: Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 2008;82:3952-3970.
12. Giorgi EE, Funkhouser B, Athreya G, et al.: Estimating time since infection in early homogeneous HIV-1 samples using a Poisson model. BMC Bioinform 2010;11:532.
13. Salazar-Gonzalez JF, Salazar MG, Learn GH, et al. and HIVAVIA Center: Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J Virol 2011;85:2751-2763.
14. Luo W, Yang H, Rathbun K, et al.: Detection of human immunodeficiency virus type 1DNAin dried blood spots by a duplex real-time PCR assay. J Clin Microbiol 2005;43:1851-1857.
15. Samleerat T, Braibant M, Jourdain G, et al.: Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01-AE. J Infect Dis 2008;98:868-876.
16. Mwapasa V, Rogerson SJ, Molyneux ME, et al.: The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004;18:1051-1059.
17. Thenin S, Samleerat T, Tavernier E, et al.: Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties. Virology 2012;426(1):12-21.
18. UNAIDS: Report on the Global AIDS Epidemic, 2008.
19. Kishko M, Somasundaran M, Brewster F, et al.: Genotypic and functional properties of early infant HIV-1 envelopes. Retrovirology 2011;8:67.
20. Kassaye S, Lee E, Kantor R, et al.: Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: Population and clonal sequence analysis. AIDS Res Hum Retroviruses 2007;23:1055-1061.
21. Becquart PN, Chomont P, Roques P, et al.: Compartmentalization of HIV-1 between breast milk and blood of HIVinfected mothers. Virology 2002;300:109-117.
22. Verani A and Lusso P: Chemokines as natural HIV antagonists. Curr Mol Med 2002;2:691-702.
23. Lewis P, Nduati R, Kreiss JK, et al.: Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 1998;177:34-39.
24. Kong X, West JT, Zhang H, et al.: The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J Virol 2008;82:11609-11618.
25. Kwiek JJ, Mwapasa V, Milner DA Jr, et al.: Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi. PLoS Med 2006;3:e10.
26. Binley JM, Wrin T, Korber B, et al.: Comprehensive crossclade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004;78:13232-13252.
27. Wu X, Parast AB, Richardson BA, et al.: Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant. J Virol 2006;80:835-844.
28. Katoh K, Kuma K, Toh H, and Miyata T: MAFFT version 5: Improvement in accuracy of multiple sequence alignment. Nucleic Acids Res 2005;33:511-518.
29. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al.: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008;105:7552-7557.
30. Li M, Salazar-Gonzalez JF, Derdeyn CA, et al.: Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol 2006;80:11776-11790.
31. Van de Perre P, Simonon A, Hitimana DG, et al.: Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 1993;341:914-918.
32. Satomi M, Shimizu M, Shinya E, et al.: Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN. J Infect Dis 2005;191:174-181.
33. Gray ES, Meyers T, Gray G, et al.: Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B. PLoS Med 2006;3:e255.
34. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
35. Nduati RW, John GC, Richardson BA, et al.: Human immunodeficiency virus type 1-infected cells in breast milk: Association with immunosuppression and vitamin A deficiency. J Infect Dis 1995;172:1461-1468.
36. van der Strate BW, Beljaars L, Molema G, et al.: Antiviral activities of lactoferrin. Antiviral Res 2001;52:225-239.
37. Abrahams M-R: Quantitating the multiplicity of infection with HIV-1 subtype C. J Virol 2009;83(8):3556-3567.
38. Dickover RE, Garratty EM, Plaeger S, and Bryson YJ: Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001;75:2194-2203.
39. Guindon S and Gascuel O: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003;52:696-704.
40. Henderson GJ, Hoffman NG, Ping LH, et al.: HIV-1 populations in blood and breast milk are similar. Virology 2004;330:295-303.
41. Shugars DC, Sweet SP, Malamud D, et al.: Saliva and inhibition of HIV-1 infection: Molecular mechanisms. Oral Dis 2002;8(Suppl 2):169-175.
42. Zhang H, Rola M, West JT, et al. Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission. Virology 2010;400:164-174.
43. Kimura M: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980;16:111-120.
44. Tamura K, Dudley J, Nei M, and Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599.